Skip to main content

Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Monday, Jan. 12, 2026.

Bernard Zovighian, chief executive officer, is scheduled to present at 11:15 a.m. PT. Scott Ullem, chief financial officer, will also participate in the conference. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/, with an archived version accessible later the same day.

About Edwards Lifesciences

Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. Discover more at www.edwards.com and follow us on LinkedIn, Facebook, Instagram and YouTube.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  226.91
+5.64 (2.55%)
AAPL  272.32
+0.48 (0.18%)
AMD  203.04
+4.93 (2.49%)
BAC  54.24
-0.30 (-0.56%)
GOOG  304.74
+6.68 (2.24%)
META  666.54
+17.04 (2.62%)
MSFT  486.77
+10.65 (2.24%)
NVDA  175.29
+4.35 (2.54%)
ORCL  180.17
+1.71 (0.96%)
TSLA  488.15
+20.89 (4.47%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.